LobbyingHemophilia Federation America lobbying by quarter
Hemophilia Federation America's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Health Issues and Insurance.
Hemophilia Federation America
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
No lobbying spend in this period.
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $0 | 1 |
| Q1 2023 | $0 | 1 |
| Q2 2023 | $0 | 1 |
| Q3 2023 | $0 | 1 |
| Q4 2023 | $0 | 1 |
| Q1 2024 | $0 | 1 |
| Q2 2024 | $0 | 1 |
| Q3 2024 | $0 | 1 |
| Q4 2024 | $0 | 1 |
| Q1 2025 | $0 | 1 |
| Q2 2025 | $0 | 1 |
| Q3 2025 | $0 | 1 |
| Q4 2025 | $0 | 1 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $0 | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$0 · 11 reports
- Insurance$0 · 8 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES11 reports
- SENATE11 reports
- Health & Human Services, Dept of (HHS)8 reports
- Centers For Medicare and Medicaid Services (CMS)7 reports
- Labor, Dept of (DOL)5 reports
- Treasury, Dept of5 reports
- Federal Trade Commission (FTC)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseHemophilia Federation of America | $0 | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| ADRIAN PALAU TEJADA | Director of Health Equity | Q3 2024 |
| MARK HOBRACZK | Director of Policy and Advocacy | Q3 2024 |
| MARY CATHERINE MOFFETT | VP Advocacy | Q3 2024 |
| RAY RIORDAN | Director of Advocacy | Q3 2024 |
| MIRIAM GOLDSTEIN | n/a | Q1 2024 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/01for Q2 | In-house | Under $5,000 |
| 04/07for Q1 2025 | In-house | Under $5,000 |
| 04/07for Q1 | In-house | Under $5,000 |
| 02/11for Q4 2025 | In-house | Under $5,000 |
| 25/10/31for Q3 2025 | In-house | Under $5,000 |
| 25/09/11for Q2 2025 | In-house | Under $5,000 |
| 25/07/12for Q2 2025 | In-house | Under $5,000 |
| 25/02/04for Q4 2024 | In-house | Under $5,000 |
| 24/10/23for Q3 2024 | In-house | Under $5,000 |
| 24/08/12for Q2 2024 | In-house | Under $5,000 |
| 24/05/08for Q1 2024 | In-house | Under $5,000 |
| 24/01/18for Q4 2023 | In-house | Under $5,000 |
| 23/10/20for Q3 2023 | In-house | Under $5,000 |
| 23/07/20for Q2 2023 | In-house | Under $5,000 |
| 23/04/19for Q1 2023 | In-house | Under $5,000 |
| 23/01/20for Q4 2022 | In-house | Under $5,000 |